Sleep issues in Parkinson’s disease

  title={Sleep issues in Parkinson’s disease},
  author={Charles H. Adler and Michael J. Thorpy},
  pages={S12 - S20}
Sleep disturbances in patients with Parkinson’s disease (PD) are common, are often severe, and are typically underrecognized and ineffectively treated. After the recognition that some patients with PD could fall asleep unexpectedly when driving, with resulting dangerous consequences, it became evident not only that PD medications might be partly responsible but that there were many additional factors contributing to sleep disturbance in these patients. This review discusses the myriad sleep… 

Tables from this paper

Sleep problems in Parkinson’s disease patients

The main causes of sleep/wake disorders in PD patients are reviewed, namely sleep fragmentation, excessive daytime sleepiness, restless legs syndrome, periodic limb movement of sleep, rapid eye movement sleep behavioral disorder and sleep apnea.

Sleep Disorders in Parkinson’s Disease

  • D. Aygun
  • Medicine, Psychology
    Parkinson's Disease - Understanding Pathophysiology and Developing Therapeutic Strategies
  • 2018
This chapter discusses the clinical features, diagnosis, comorbidities, management, and pathogenesis of sleep disorders in PD under the literature light and describes the most appropriate treat- ment considerations.

Managing sleep disorders in Parkinson’s disease

An overview of the most common disturbances of nocturnal sleep and daytime alertness in patients with Parkinson’s disease, with special emphasis on diagnosis and therapeutic strategies is provided.

Chapter 1 Sleep Disorders in Parkinson ’ s Disease

This chapter discusses the clinical features, diagnosis, comorbidities, management, and pathogenesis of sleep disorders in PD under the literature light and describes the most appropriate treatment considerations.

Sleep Disturbances in Parkinson's Disease

The aim of this study is to assess the nature of sleep disturbance in PD and to correlate the PSG variables with the clinical findings and several sleep scales.

[Heterogeneity of excessive daytime sleepiness in Parkinson's disease].

The main factors of the development of daytime sleepiness in Parkinson's disease and key points of the pathogenesis of «primary» daytimeSleepiness are discussed.

Excessive Daytime Sleepiness in Patients with Parkinson’s Disease

The efficacy of pharmacological treatment of EDS in Parkinson’s disease using wakefulness-promoting drugs such as modafinil remains controversial, and further areas of research are now also focusing on adenosine A2A receptor antagonists, sodium oxybate and caffeine to promote wakefulness.

Insomnia in Parkinson’s Disease

A dedicated sleep interview that includes patients’ bed partners or care givers is a necessary diagnostic step in the management of insomnia.

Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

The issues of excessive daytime sleepiness and unintended sleep episodes in patients with Parkinson's disease (PD) are looked at and the reasons why patients might suffer from these symptoms are explored, and what steps could be taken to manage them.

Sleep disorders in Parkinson’s disease

  • C. Comella
  • Psychology, Medicine
    Current treatment options in neurology
  • 2008
Excessive daytime sleepiness related to the use of direct dopaminergic agonists may improve with dosage reduction or discontinuation, and Stimulants such as modafinil may provide modest benefit.



Sleep disorders in Parkinson's disease.

Management is difficult and should be targeted to the specific sleep disorder and its likely cause, and simple sleep measures such as sleep hygiene should be tried first before pharmacological treatment is initiated.

Sleep and Parkinson's disease.

  • T. Freedom
  • Psychology, Medicine
    Disease-a-month : DM
  • 2007

Sleep disturbances in Parkinsonism

  • J. Askenasy
  • Psychology, Medicine
    Journal of Neural Transmission
  • 2003
A model based on 3 steps in the treatment of sleep disturbances in Parkinson's Disease patients is suggested, allowing the patient, the spouse or the caregiver a quiet sleep at night, may postpone the retirement and the institutionalization of the PD patient.

Autonomic Complications of Parkinson’s Disease

Although not as severe as the autonomic failure of the Shy-Drager and multiple system atrophy disorders, autonomic dysfunction nevertheless frequently causes problems in patients with Parkinson’ s disease (PD), studies showing that more than 90% of patients with PD experience autonomic symptoms during the course of the disease.

The Association between Disease Severity and Sleep-Related Problems in Patients with Parkinson’s Disease

It is concluded that depressive symptoms and increasing levodopa doses in PD patients mainly cause sleep onset difficulties and sleep interruptions, while the severity of motor symptoms contributes to sleep-related events like sleep walking, heavy sweating and nightmares.

A community‐based study of sleep disorders in patients with Parkinson's disease

The strong correlation between depression and sleep disorders in patients with Parkinson's disease underlines the importance of identifying and treating both conditions in these patients.

Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis

Clinical and experimental observations suggest that serotonergic mechanisms are important in this symptom complex and it is suggested that sleep-related symptoms constitute an early stage of levodopa-induced dopaminergic psychiatric toxicity in the parkinsonian population.

Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease With Modafinil

Modafinil may be effective in reducing EDS in patients with Parkinson's disease treated with dopaminergic drugs and may allow further increase in dopamine agonist therapy in patients previously unable to tolerate this because of EDS.

Parkinson’s disease and sleepiness: An integral part of PD

In patients with PD preselected for sleepiness, severity of sleepiness was not dependent on nocturnal sleep abnormalities, motor and cognitive impairment, or antiparkinsonian treatment.